Human Brain Project

Human Brain Project
Name	Human Brain Project
Formation	2013
Type	Research initiative
Headquarters	Geneva
Leader title	Director

Human Brain Project

The Human Brain Project was a large-scale European neuroscience initiative launched in 2013 to integrate research on the brain across multiple scales, from molecules to behavior. It brought together neuroscientists, clinicians, computer scientists, engineers, philosophers, and ethicists from institutions such as École Polytechnique Fédérale de Lausanne, University of Oxford, Karolinska Institutet, Max Planck Society, and University of Heidelberg to build shared infrastructures and computational platforms. The initiative interacted with entities including European Commission, Human Genome Project, Blue Brain Project, Allen Institute for Brain Science, and industry partners like IBM, Microsoft, and Siemens.

Overview

The project aimed to create a unified research ecosystem linking experimental programs at University College London, University of Barcelona, Utrecht University, École Normale Supérieure (Paris), Sorbonne University, University of Zurich, Imperial College London, Technical University of Munich, ETH Zurich, and Karlsruhe Institute of Technology. It combined expertise from consortia including CNRS, CERN, European Molecular Biology Laboratory, Sage Bionetworks, RIKEN, Institute Pasteur, Weizmann Institute of Science, Cold Spring Harbor Laboratory, Harvard University, Massachusetts Institute of Technology, Stanford University, University of California, San Francisco, and Johns Hopkins University. The initiative interfaced with databases and projects such as Neuroscience Information Framework, NeuroMorpho.Org, BrainMap, Human Connectome Project, OpenWorm, and BRAIN Initiative.

Objectives and Scope

Primary objectives included construction of multiscale computational models, development of neuromorphic hardware, creation of data-sharing platforms, and acceleration of translational research linking basic science to clinical practice at institutions like Karolinska University Hospital, Mayo Clinic, University College Hospital, and Charité – Universitätsmedizin Berlin. Scope encompassed cellular neurophysiology at Max Planck Institute for Brain Research, synaptic and circuit modeling at Cold Spring Harbor Laboratory, neuroimaging pipelines used by NeuroSpin, connectomics work at Howard Hughes Medical Institute, and pharmacological databases maintained by European Medicines Agency collaborators. The project sought interoperability with standards from International Neuroinformatics Coordinating Facility, Digital Object Identifier, OpenAIRE, and platforms developed at Barcelona Supercomputing Center and Jülich Research Centre.

Organization and Governance

Governance structures involved an executive board, scientific advisory board, ethics advisory board, and project office drawing members from Swiss Federal Institute of Technology in Lausanne, University of Edinburgh, Karolinska Institutet, École Polytechnique, Max Planck Society, CNRS, CERN, European Commission Directorate-General for Research and Innovation, European Research Council, and national research agencies such as National Institute for Health and Care Research and German Research Foundation. Collaborative agreements linked the project with funding bodies including Wellcome Trust, Gates Foundation, National Institutes of Health, Agence Nationale de la Recherche, Netherlands Organisation for Scientific Research, Austrian Science Fund, and regional initiatives like Horizon 2020. Oversight mechanisms referenced precedents from Human Genome Project governance, Policymaking in the European Union, and institutional review frameworks at Université de Lausanne and University of Cambridge.

Scientific Workstreams and Platforms

Scientific workstreams included computational neuroscience programs at Blue Brain Project (EPFL), large-scale simulation efforts on supercomputers at Jülich Supercomputing Centre, neuromorphic engineering with partners such as Institute of Neuroinformatics (ETH Zurich/University of Zurich), and machine-learning integration drawing on research from DeepMind, Facebook AI Research, OpenAI, Google DeepMind, and academic groups at University of Toronto and Carnegie Mellon University. Platforms delivered encompassed data repositories interoperable with EBI, EMBL-EBI, Gene Expression Omnibus, and imaging resources at Human Connectome Project sites. Experimental pipelines interfaced with laboratories at Salk Institute, University of Barcelona's Drosophila facility, Max Delbrück Center for Molecular Medicine, Riken Center for Brain Science, and clinical cohorts at Guy's and St Thomas' NHS Foundation Trust and Mount Sinai Health System. The project fostered tools for connectomics, neuroinformatics, electrophysiology, multimodal imaging, and cognitive modeling linked to work at Allen Institute, McGovern Institute for Brain Research, Princeton Neuroscience Institute, Yale School of Medicine, and Columbia University.

Ethics, Legal and Societal Implications

An Ethics and Society subproject convened ethicists from University of Oxford's Ethox Centre, legal scholars from Harvard Law School, philosophers from University of Cambridge, and social scientists from London School of Economics, addressing issues related to privacy laws like General Data Protection Regulation interpreted alongside standards from World Health Organization and clinical regulations upheld by European Medicines Agency and national health authorities such as NHS England. The board engaged with stakeholder groups including patient advocacy organizations at Alzheimer's Association, Parkinson's Foundation, Schizophrenia Research Fund, and disability rights networks affiliated with European Disability Forum. Discussions drew on precedents from bioethics cases at Tuskegee syphilis study, regulatory frameworks from Declaration of Helsinki, and data ethics guidance from OECD.

Funding, Timeline and Milestones

Initial funding originated from the European Commission under the FP7 transition to Horizon 2020, supplemented by grants from Wellcome Trust, European Research Council, national agencies including Swedish Research Council, German Federal Ministry of Education and Research, Swiss National Science Foundation, and in-kind contributions from partners such as IBM Research, Intel Labs, and NVIDIA. Major milestones included launch in 2013, platform rollouts between 2015–2018, mid-term reviews involving European Commission Horizon 2020 Independent Expert Review, restructuring in 2016, and continued consolidation through collaborations with Blue Brain Project and data initiatives like Human Connectome Project and Allen Brain Atlas.

Criticism and Impact

The initiative attracted criticism from neuroscientists at institutions including University College London, MIT, Harvard Medical School, and Columbia University over priorities, reproducibility, and resource allocation; prominent critics referenced approaches by groups at Salk Institute and computational programs at Princeton University. Debates involved commentators from Nature, Science, The Lancet, and policy analyses by European Science Foundation. Supporters cited advances in infrastructure, interoperability standards, and collaborations with Blue Brain Project, Barcelona Supercomputing Center, Jülich Research Centre, and industry partners that influenced neuromorphic hardware efforts at ETH Zurich and algorithmic research at DeepMind and Facebook AI Research. The long-term impact included contributions to open data practices used by Human Connectome Project, methodological cross-fertilization with connectomics labs at Harvard University, and training networks linked to Marie Skłodowska-Curie Actions and doctoral programs at EPFL and University of Cambridge.

Category:Neuroscience projects